Covered recipient · General Payments record
PIERRE-YVES M CHEVRAY
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$5,393.88
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,156.89 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Mentor Worldwide LLC | $358.12 | 4 |
| ABBVIE INC. | $209.00 | 4 |
| TELA Bio, Inc. | $166.55 | 1 |
| AXOGEN | $155.14 | 3 |
| Ethicon US, LLC | $116.42 | 1 |
| Medtronic, Inc. | $80.41 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $27.79 | 1 |
| Integra LifeSciences Corporation | $23.16 | 1 |
| Smith & Nephew, Inc. | $20.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.07 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457934 | CMS |
| ABBVIE INC. | $131.57 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457936 | CMS |
| ABBVIE INC. | $25.15 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457938 | CMS |
| ABBVIE INC. | $27.21 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457940 | CMS |
| AXOGEN | $102.39 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143635812 | CMS |
| AXOGEN | $28.35 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143640122 | CMS |
| AXOGEN | $24.40 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143640799 | CMS |
| Ethicon US, LLC | $116.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077648514 | CMS |
| Integra LifeSciences Corporation | $23.16 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140125615 | CMS |
| Medtronic, Inc. | $80.41 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119271184 | CMS |
| Mentor Worldwide LLC | $148.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077619226 | CMS |
| Mentor Worldwide LLC | $148.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077619406 | CMS |
| Mentor Worldwide LLC | $30.52 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077619558 | CMS |
| Mentor Worldwide LLC | $30.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077619662 | CMS |
| Smith+Nephew, Inc. | $20.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149577178 | CMS |
| TELA Bio, Inc. | $166.55 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154269693 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $27.79 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105909088 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.